1272 Two-year experience of BITOX: the Belgian multidisciplinary ImmunoTOXicity board, a nationwide initiative of the Belgian Society for Medical Oncology (BSMO)
| Verfasser: | |
|---|---|
| Dokumenttyp: | proceedings-article |
| Erscheinungsdatum: | 2023 |
| Verlag/Hrsg.: |
BMJ Publishing Group Ltd
|
| Sprache: | unknown |
| Permalink: | https://search.fid-benelux.de/Record/base-27315204 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | http://dx.doi.org/10.1136/jitc-2023-sitc2023.1272 |
